-
If it were easier for women to obtain emergency contraception (EC), would it result in an increase in unprotected intercourse, cause women to forego their current method of contraception, or increase the risk of sexually transmitted diseases (STDs)? Apparently not, according to the findings of a just-published study.
-
Just-released information from the National Survey of Family Growth offers family planning clinicians a mix of good and bad news: While sexually active teens are more likely to be using contraception, many teens are uninformed about birth control choices.
-
What are some emerging trends in other sexually transmitted diseases (STDs) in the United States? Check the following highlights from the Atlanta-based Centers for Disease Control and Preventions (CDC) 2003 STD Surveillance Report.
-
Efforts to lower the rates of gonorrhea in the United States are dipping figures to all-time lows, but work remains to erase racial disparities and combat growing drug resistance to the sexually transmitted disease (STD).
-
The next patient in your exam room is an adolescent female, who says shes interested in birth control pills. Her chief focus? While shes interested in contraception, she asks several questions about an acne pill.
-
The Food and Drug Administration (FDA) has strengthened the warning information on the labeling for the abortion drug mifepristone. The labeling change is in response to reports of infection, bleeding, and death among women who have taken the drug, according to the FDA.
-
In late September 2004, the Department of Health and Human Services announced a new round of national and regional grantees for the infant adoption awareness-training program. Given the dubious track record of this program during its first three years of operation, many family planning providers are hopeful that this will bring much-needed changes to the national training curriculum.
-
What is your approach when checking for copper allergy in women considering use of the Copper T380A (ParaGard, FEI, Addison, TX)? What are your directions on use of the levonorgestrel-only EC, Plan B (Barr Pharmaceuticals, Pomona, NY)?
-
Put your diagnostic skills into high gear to spot lymphogranuloma venereum (LGV), a sexually transmitted disease caused by a type
of Chlamydia trachomatis.
-
Researchers are taking a hard look at the forgotten half of the transmission equation of human papillomavirus (HPV). Investigators are recruiting 3,000 healthy men, ages 18 to 44, in the United States, Mexico, and Brazil to determine mens roles in spreading the sexually transmitted organism, which is linked to cervical cancer in women.